International Stem Cell CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Paul Maier V, a Director of International Stem Cell CORP, reported a transaction in 30,000 shares of common stock on September 16, 2026.
OQB
Paul Maier V, a Director of International Stem Cell CORP, sold 32,802 shares of common stock on September 11, 2026 for $0.32 per share.
OQB
International Stem Cell Corp's Director Don Wright was granted 562,786 stock options with an exercise price of $0.13, vesting through June 2026 and expiring in June 2035.
OQB
Paul V. Maier, a Director at International Stem Cell Corp., was granted stock options for a total of 562,786 shares of common stock with an exercise price of $0.13 per share.
OQB
Director Don Wright acquired stock options in International Stem Cell CORP on June 11, 2024.
OQB
Paul V. Maier, a director at International Stem Cell CORP, reports the acquisition of stock options.